For more than a century, the name itself has misled. Human African trypanosomiasis, better known as sleeping sickness, has been understood as a disease defined by excessive sleep. But the reality, researchers now argue, is far more complex, and the name obscures a deeper truth about how the parasite attacks the brain’s most fundamental rhythms.
A new narrative review published in Clocks & Sleep proposes an integrated framework called Trypanosome-Associated Sleep Disorder, or TASD, to capture the full scope of how the parasite Trypanosoma brucei dismantles the human sleep-wake architecture. Rather than simply inducing hypersomnolence, the disease produces a profound disintegration of circadian timing, a fragmentation of sleep structure, and a progressive neuroinflammatory cascade that may leave permanent marks on the brain’s clockwork.
The disease that is not what it seems
Human African trypanosomiasis is a neglected tropical disease transmitted by the tsetse fly across sub-Saharan Africa. Left untreated, it is almost always fatal. But what sets it apart from other parasitic infections is the way it targets the central nervous system. The trypanosomes cross the blood-brain barrier, invade the brain, and settle in regions that govern the body’s most basic timing systems.
Patients do not simply sleep too much. Their sleep-wake cycles invert. They experience uncontrollable daytime sleep episodes, nighttime insomnia, fragmented sleep architecture, and a progressive loss of the normal 24-hour organization of rest and activity. The circadian rhythm, the internal clock that aligns physiology with the day-night cycle, begins to break down.
The review, authored by Seithikuruppu R. Pandi-Perumal, Ahmed S. BaHammam, and Konda Mani Saravanan, synthesizes decades of research into a coherent framework. The central insight: sleep-wake disruption in HAT is not a single symptom. It is a layered process with distinct stages, each driven by different pathological mechanisms.
A three-stage model of circadian collapse
The authors outline a three-stage progression of sleep-wake dysfunction in HAT. In the first stage, the parasites cross the blood-brain barrier and trigger a systemic inflammatory response. Pro-inflammatory cytokines, including interleukin-1 and tumor necrosis factor-alpha, begin to alter sleep regulation. This produces excessive daytime sleepiness and the earliest signs of sleep fragmentation. The circadian system is still intact but under stress.
In the second stage, the inflammation deepens. The parasites establish themselves within the brain parenchyma, and the immune response shifts into a chronic, damaging mode. The kynurenine pathway, a metabolic route linked to tryptophan breakdown, becomes hyperactivated. This produces neurotoxic metabolites that interfere with neurotransmitter systems and directly damage neurons. The suprachiasmatic nucleus of the hypothalamus, the brain’s master circadian pacemaker, begins to suffer. Clock gene expression becomes dysregulated. The normal alternation of sleep and wake states starts to lose its synchronicity with the external world.
In the third and most advanced stage, the damage to the circadian system is severe. The suprachiasmatic nucleus is structurally compromised. The rhythmic expression of core clock genes such as CLOCK, BMAL1, PER, and CRY is disrupted. Melatonin secretion patterns, which normally rise at night to signal sleep readiness, become erratic or flat. Patients exhibit a complete inversion of the sleep-wake cycle, with no stable relationship between their rest-activity patterns and the time of day.
The kynurenine pathway as a key mechanism
One of the review’s most significant contributions is the attention it gives to the kynurenine pathway, a system that has received relatively little attention in the context of HAT. Under normal conditions, the body uses this pathway to metabolize tryptophan. But when inflammation is present, the pathway shifts toward the production of quinolinic acid and other neurotoxic metabolites.
These metabolites act as N-methyl-D-aspartate receptor agonists, meaning they overstimulate neurons in a way that can cause excitotoxicity and cell death. In the context of HAT, the kynurenine pathway may explain not only the circadian disruption but also the irreversible neurological damage that persists in some patients even after successful antiparasitic treatment. The authors suggest that this pathway could serve as a therapeutic target, offering a way to protect the brain’s timing centers while the infection itself is being treated.
Why the framework matters
The TASD framework matters for several reasons. First, it reframes the disease in a way that better matches clinical reality. Instead of focusing narrowly on hypersomnia, it recognizes the full spectrum of sleep-wake disturbances. This has practical implications for diagnosis and patient counseling.
Second, it highlights the gaps in current knowledge. Reliable biomarkers for staging sleep-wake dysfunction in HAT do not yet exist. The relationship between peripheral inflammation and central circadian damage is not fully mapped. The point at which neuronal damage becomes irreversible is unknown, and current staging systems for HAT do not adequately capture the circadian dimension of the disease.
Third, it opens new avenues for treatment. If the kynurenine pathway is a driver of both circadian disruption and neuronal injury, then inhibitors of key enzymes in that pathway could be repurposed or developed for HAT. Similarly, chronotherapeutic approaches, timed interventions designed to reinforce circadian signals, could be tested in combination with standard antiparasitic drugs.
A model for other neuroinflammatory disorders?
The authors note that the mechanisms identified in HAT may have relevance beyond this single disease. The same inflammatory cascades, the same disruption of clock genes, and the same damage to the suprachiasmatic nucleus appear in other conditions, including Alzheimer disease, Parkinson disease, and multiple sclerosis. Understanding how trypanosomes dismantle the circadian system could illuminate pathways that are common to many neurodegenerative and neuroinflammatory illnesses.
For now, the TASD framework provides a much needed conceptual map. Sleeping sickness is not just a disease of excessive sleep. It is a disease of broken time, where the parasite hijacks the body’s clock and gradually dismantles it from within. Recognizing that is the first step toward better diagnosis, better staging, and ultimately better treatment for a disease that has been neglected for too long.